Menu
Search
|

Menu

Close
X

Baxter International Inc BAX.N (New York Stock Exchange)

66.33 USD
-0.11 (-0.17%)
As of Feb 17
chart
Previous Close 66.44
Open 66.31
Volume 958,175
3m Avg Volume 756,788
Today’s High 67.10
Today’s Low 66.28
52 Week High 72.58
52 Week Low 49.03
Shares Outstanding (mil) 544.87
Market Capitalization (mil) 34,277.83
Forward P/E 38.37
Dividend (Yield %) 0.16 ( 1.02 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.29 Mean rating from 17 analysts

KEY STATS

Revenue (mm, USD)
FY17
10,561
FY16
10,163
FY15
9,968
EPS (USD)
FY17
1.304
FY16
8.996
FY15
0.714
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
38.37
32.90
Price to Sales (TTM)
vs sector
3.33
5.77
Price to Book (MRQ)
vs sector
3.73
5.41
Price to Cash Flow (TTM)
vs sector
20.32
23.42
Total Debt to Equity (MRQ)
vs sector
37.68
16.52
LT Debt to Equity (MRQ)
vs sector
37.65
12.22
Return on Investment (TTM)
vs sector
6.78
14.43
Return on Equity (TTM)
vs sector
10.22
16.13

EXECUTIVE LEADERSHIP

Jose Almeida
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $1,300,000.00
Bonus: $3,510,000.00
James Saccaro
Corporate Vice President and Chief Financial Officer, Since 2015
Salary: $644,415.00
Bonus: $1,056,820.00
Giuseppe Accogli
Senior Vice President, President - Global Businesses, Since 2017
Salary: $514,028.00
Bonus: $775,005.00
Brik Eyre
Senior Vice President, President - Americas, Since 2017
Salary: $618,533.00
Bonus: $954,986.00
Marcus Schabacker
Chief Scientific Officer, Corporate Vice President, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1 Baxter Pkwy
DEERFIELD   IL   60015-4625

Phone: +1847.9482000

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

SPONSORED STORIES